Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma

BACKGROUND: In the era of cytokines, patients with brain metastases (BM) from renal cell carcinoma had a significantly shorter survival than patients without. Targeted agents (TA) have improved the outcome of patients with metastatic renal cell carcinoma (mRCC) however, their impact on patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vogl, Ursula M, Bojic, Marija, Lamm, Wolfgang, Frischer, Josa M, Pichelmayer, Oskar, Kramer, Gero, Haitel, Andrea, Kitz, Klaus, Harmankaya, Kaan, Zielinski, Christoph C, Schmidinger, Manuela
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2942853/
https://ncbi.nlm.nih.gov/pubmed/20819239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-480
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados